Table 1 Demographic and clinical data of patients (n = 88)
Age; year | |
Mean | 58.7 |
SD | 12.9 |
Sex; number (%) | |
Male | 48 (54.5) |
Female | 40 (45.5) |
Site of Cancer; number(%) | |
Colon | 64 (72.7) |
Rectum | 24 (27.3) |
Tumor stage; number(%) | |
Stage 2a | 9 (12.3) |
Stage 2b | 8 (11) |
Stage 2c | 3 (4.1) |
Stage 3a | 3 (4.1) |
Stage 3b | 14 (19.2) |
Stage 3c | 6 (8.2) |
Stage 4a | 25 (34.2) |
Stage 4b | 5 (6.9) |
Chemotherapy; number of cycles(%) | |
FOLFOX | 165 (72.7) |
FOLFIRI | 47(20.7%) |
Capecitabine + Cetuximab | 3 (1.3) |
Capecitabine | 6 (2.7) |
FOLOFOX-IRI | 5 (2.2) |
5-FU | 1 (0.4) |